Immunoreactive insulin and C-peptide responses to various insulin secretory stimuli in subjects with type 2 diabetes and in control subjects during continuous glucose monitoring.
D000328:Adult; D001786:Blood Glucose / Q000032:analysis*; D002096:C-Peptide / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000145:classification / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D005502:Food; D005934:Glucagon / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D007328:Insulin / Q000276:immunology / Q000378:metabolism* / Q000627:therapeutic use; D000078790:Insulin Secretion; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000378:metabolism*; D012636:Secretory Rate / Q000187:drug effects; D013726:Terbutaline / Q000494:pharmacology
D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D010455:Peptides; D005934:Glucagon; D005947:Glucose; D013726:Terbutaline